BioCrude Technologies USA, Inc. Proceeds from Loans
BioCrude Technologies USA, Inc. reported Proceeds from Loans of $9.25 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLoans · last filed 2021-02-12
- BioCrude Technologies USA, Inc. proceeds from loans for the quarter ending 2020-12-31 was $0.00.
- BioCrude Technologies USA, Inc. proceeds from loans for the quarter ending 2020-09-30 was $0.00.
- BioCrude Technologies USA, Inc. proceeds from loans for the quarter ending 2020-06-30 was $0.00.
- BioCrude Technologies USA, Inc. proceeds from loans for the quarter ending 2020-03-31 was $9.25K.
- BioCrude Technologies USA, Inc. proceeds from loans for fiscal 2020 was $9.25K, a 9.42% decline from fiscal 2019.
- BioCrude Technologies USA, Inc. proceeds from loans for fiscal 2019 was $10.21K.
| Period end | Proceeds from Loans 3 month | Proceeds from Loans 6 month | Proceeds from Loans 9 month | Proceeds from Loans 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $0.00 derived: sum of 2 quarters · filed 2021-02-12 | $0.00 derived: sum of 3 quarters · filed 2021-02-12 | $9.25K 10-K · filed 2021-02-12 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | $9.25K 10-Q · filed 2020-11-10 | $9.21K derived: sum of 4 quarters · filed 2021-02-12 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $9.25K 10-Q · filed 2020-08-10 | $9.21K derived: sum of 3 quarters · filed 2021-02-12 | $6.93K derived: sum of 4 quarters · filed 2021-02-12 |
| 2020-03-31 | $9.25K 10-Q · filed 2020-05-12 | $9.21K derived: sum of 2 quarters · filed 2021-02-12 | $6.93K derived: sum of 3 quarters · filed 2021-02-12 | |
| 2019-12-31 | -$45.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | -$2.32K derived: sum of 2 quarters · filed 2021-02-12 | $10.21K 10-K · filed 2021-02-12 | |
| 2019-09-30 | -$2.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $10.26K 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $12.54K 10-Q · filed 2020-08-10 |